HeartBeam has announced a partnership with electrocardiogram (ECG)-based diagnostics software company AccurKardia, aimed at improving cardiac monitoring solutions’ accessibility. The alliance …
Roche posted flat diagnostics sales in Q1 2025, impacted by recent healthcare pricing reforms in China. The big pharma company’s sales …
Boston Scientific has reported positive 12-month primary endpoint outcomes from the ADVANTAGE AF trial’s second phase, assessing the Farapulse pulsed …
Medtronic has signed an agreement for the distribution of Dragonfly Endoscopy’s pancreaticobiliary system in the US. The agreement’s financial terms remain …
Thermo Fisher has outlaid $2bn to expand manufacturing and development in the US, joining the long list of companies directing …
The Global Health Innovative Technology (GHIT) Fund has awarded a $4.5m grant to US-based diagnostic developer Fluxus, a Fujirebio subsidiary, …
Intuitive Surgical reported a strong Q1 but cautioned that future tariffs could have an “adverse impact” on its 2025 financial …
Roche has introduced its Chest Pain Triage algorithm, designed to rapidly identify acute coronary syndrome (ACS). This algorithm, part of the …
Becton, Dickinson and Company (BD) has received the US Food and Drug Administration’s (FDA) 510(k) clearance for the Phasix ST …
The landscape of contraception for women has seen minimal change over the past 50 years, with successive generations often relying …
Australia-based company Epiminder has received Food and Drug Administration (FDA) authorisation through the De Novo classification for its implantable continuous …
Heart disease remains one of the leading causes of mortality worldwide, with the World Health Organization estimating that it causes …
Vivasure Medical has received CE mark approval for its PerQseal Elite vascular closure system, providing a new bioresorbable option for …
Novocure has obtained CE Mark approval for its Optune Lua device to treat adults with metastatic non-small cell lung cancer …
Catalysed by the sweeping tariffs agenda being implemented by President Donald Trump's administration in the US, the era of “easy …
